Polio, or poliomyelitis, is a viral disease that once caused widespread paralysis and disability around the world. Global vaccination campaigns have dramatically reduced the number of cases over the past several decades, bringing the world closer to eradicating the disease. However, discussions about polio vaccination sometimes include the topic of vaccine-derived poliomyelitis, a rare event linked to certain strains used in oral polio vaccines. Understanding which strain can lead to vaccine-derived poliovirus and how this situation occurs helps clarify why vaccination programs remain essential for controlling and eventually eliminating polio.
Understanding Poliomyelitis and the Poliovirus
Poliomyelitis is caused by the poliovirus, a highly contagious virus that spreads primarily through the fecal-oral route. The virus can enter the body through contaminated food, water, or hands. Once inside the body, it multiplies in the intestines and can invade the nervous system.
Most people infected with poliovirus do not experience serious symptoms. Some may develop mild illness with fever, fatigue, sore throat, or stomach discomfort. In a small percentage of cases, however, the virus attacks nerve cells in the spinal cord, leading to paralysis. This paralysis can be temporary or permanent and may affect the legs, arms, or breathing muscles.
There are three main serotypes, or strains, of wild poliovirus
- Wild poliovirus type 1 (WPV1)
- Wild poliovirus type 2 (WPV2)
- Wild poliovirus type 3 (WPV3)
Vaccination programs have successfully eliminated types 2 and 3 in the wild, while type 1 remains the only wild strain still circulating in a few regions.
Types of Polio Vaccines
Two main types of vaccines have been used to prevent poliomyelitis. Each works differently but aims to protect individuals and communities from poliovirus infection.
Inactivated Polio Vaccine (IPV)
The inactivated polio vaccine contains killed poliovirus that cannot replicate in the body. It is given by injection and stimulates the immune system to produce protective antibodies. IPV is widely used in many countries because it cannot cause vaccine-derived infection.
Oral Polio Vaccine (OPV)
The oral polio vaccine contains a weakened, live form of the poliovirus. It is administered as drops taken by mouth. OPV has been extremely effective in reducing polio worldwide because it creates strong intestinal immunity and helps stop transmission of the virus.
However, because OPV contains a weakened live virus, there is a very small possibility that the virus can mutate over time under certain conditions.
What Is Vaccine-Derived Poliomyelitis?
Vaccine-derived poliomyelitis occurs when the weakened virus used in the oral polio vaccine changes genetically and regains the ability to cause disease. This situation is extremely rare and typically happens only in communities where vaccination coverage is low.
When the weakened vaccine virus is excreted by a vaccinated person, it can circulate in areas with poor sanitation. In most cases, this spread is harmless and may even help boost immunity in the community. But if the virus continues to circulate for a long time in under-immunized populations, it may accumulate genetic changes.
After enough mutations, the virus can regain characteristics similar to wild poliovirus and potentially cause paralysis. This mutated form is called vaccine-derived poliovirus, often abbreviated as VDPV.
Which Strain Causes Vaccine-Derived Poliomyelitis
The strain most commonly associated with vaccine-derived poliomyelitis is poliovirus type 2 from the oral polio vaccine. Historically, the type 2 component of the vaccine has been responsible for the majority of circulating vaccine-derived poliovirus cases.
This occurs because the type 2 strain used in earlier oral polio vaccines had a higher tendency to genetically revert compared with the other strains. As a result, most reported vaccine-derived outbreaks have involved type 2 poliovirus.
For this reason, global vaccination programs introduced major changes to the oral polio vaccine formulation. In 2016, many countries switched from the trivalent oral polio vaccine, which contained types 1, 2, and 3, to the bivalent version that includes only types 1 and 3.
The removal of the type 2 component from routine vaccination was designed to reduce the risk of vaccine-derived poliovirus associated with that strain.
Types of Vaccine-Derived Poliovirus
Vaccine-derived poliovirus can appear in several forms depending on how it spreads and whom it affects. Public health experts classify these cases into different categories.
Circulating Vaccine-Derived Poliovirus (cVDPV)
This occurs when the mutated vaccine virus spreads within a community. Circulating vaccine-derived poliovirus is the most significant form because it can cause outbreaks similar to those caused by wild poliovirus.
Immunodeficiency-Associated Vaccine-Derived Poliovirus (iVDPV)
In rare situations, individuals with weakened immune systems may carry the vaccine virus for extended periods. Because their immune systems cannot eliminate the virus quickly, it may mutate over time.
Ambiguous Vaccine-Derived Poliovirus (aVDPV)
This classification is used when the source of the vaccine-derived virus cannot be clearly identified. It may be detected through environmental surveillance or isolated cases.
Why Vaccine-Derived Poliovirus Occurs
The main factor that allows vaccine-derived poliovirus to emerge is low vaccination coverage. When a large portion of a community is fully vaccinated, the virus cannot spread easily and quickly disappears.
However, if many people remain unvaccinated, the weakened virus from the oral vaccine may circulate for longer periods. During this time, genetic changes can occur, increasing the risk of mutation.
Several conditions increase the likelihood of vaccine-derived poliovirus
- Low routine immunization rates
- Poor sanitation and hygiene conditions
- Limited access to healthcare services
- Delayed outbreak detection
Maintaining strong vaccination coverage is therefore the most effective way to prevent both wild polio and vaccine-derived polio.
Global Efforts to Address the Risk
International health organizations continuously monitor poliovirus activity around the world. Surveillance systems track cases of paralysis and test sewage samples to detect poliovirus circulation.
When vaccine-derived poliovirus is detected, rapid vaccination campaigns are usually organized to stop the spread. These campaigns aim to immunize as many people as possible in a short time.
Scientists have also developed newer versions of the oral polio vaccine designed to be genetically more stable. These updated vaccines are less likely to mutate and are used in certain outbreak responses.
The Importance of Continued Polio Vaccination
Despite concerns about vaccine-derived poliovirus, vaccination remains the most effective tool for preventing poliomyelitis. The benefits of immunization far outweigh the extremely small risk associated with vaccine-derived strains.
Without vaccination programs, wild poliovirus would spread rapidly and cause far more cases of paralysis. In fact, before vaccines were widely available, polio outbreaks affected hundreds of thousands of people each year.
Modern vaccination strategies combine the strengths of both oral and inactivated polio vaccines. Many countries now use the inactivated polio vaccine in routine schedules while still using oral vaccines during outbreak responses.
Looking Toward Polio Eradication
The world has made remarkable progress toward eliminating poliomyelitis. Global cases of wild poliovirus have decreased by more than 99 percent since the launch of international eradication campaigns in the late twentieth century.
However, until polio is completely eradicated, both wild and vaccine-derived strains remain a concern. Continued surveillance, strong immunization programs, and rapid response to outbreaks are essential to achieving the final goal.
Understanding which strain is linked to vaccine-derived poliomyelitis, particularly the type 2 poliovirus strain used in earlier oral vaccines, helps explain the adjustments made in global vaccination strategies. Through sustained commitment and scientific innovation, the world continues moving closer to a future where poliomyelitis no longer threatens children and communities anywhere.